REBEKAH BEATY: Open Payments
NPI 1912497058 · WEST BADEN SPRINGS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$851 in 39 payments from 17 companies in 2025. Trend: 2023 $526 · 2024 $415 · 2025 $851
Food & beverage: $851
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 5 | $144 |
| Novo Nordisk Inc | 3 | $133 |
| Otsuka America Pharmaceutical, Inc. | 6 | $116 |
| Alkermes, Inc. | 5 | $85 |
| Amgen Inc. | 3 | $55 |
| ABBVIE INC. | 3 | $48 |
| AstraZeneca Pharmaceuticals LP | 3 | $48 |
| IDORSIA PHARMACEUTICALS US INC | 2 | $34 |
| Vanda Pharmaceuticals Inc. | 1 | $26 |
| E.R. Squibb & Sons, L.L.C. | 1 | $25 |
Products named: Auvelity, REXULTI, Wegovy, ARISTADA, OTEZLA, Ozempic, Quviviq, VRAYLAR.
Industry payments across IN — which companies pay providers there.
